Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
Sanofi-Genzyme Joins $12M Round for T-Cell Therapy Startup, Unum 10/21/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Well-Traveled Rhodes Leaves Epizyme For Atlas Venture Partnership 09/29/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Bush, Draper Back Health IT Startup Wellframe as Sector Heats Up 04/07/14 Boston
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Blueprint Medicines Hauls in $25M For Cancer Drug Push 01/07/14 Boston
Blueprint Medicines Secures $25,000,000 Series B Round 01/07/14 Boston
ViewRay Lands $30,000,000 New Funding 12/17/13 Detroit
ViewRay Secures $30,000,000 New Financing 12/17/13 Detroit
Proteostasis, Biogen Team up on Protein Homeostasis Drugs 12/09/13 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Dimension, Backed by Fidelity, Targets Hemophilia With Gene Therapy 10/31/13 Boston
Why Deborah Dunsire’s Unusual Bet on Alzheimer’s Makes Sense 07/31/13 Boston
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Dunsire Returns to Action to Tackle CNS Disorders With EnVivo 07/11/13 Boston
Blueprint Medicines Combs Through Genome for the Next Gleevec(s) 03/20/13 Boston
Kyruus Lands $11,000,000 Series B Financing 01/02/13 Boston
Ultragenyx, Led by BioMarin Vet, Snags $75M for Ultra-Rare Diseases 12/20/12 San Francisco
Ultragenyx Pharmaceutical Obtains $75,000,000 Series B Round 12/20/12 San Francisco
Procured Health Garners $1,100,000 Seed Round 08/04/12 Detroit
Aveo, Mersana, Haemonetics, & More from the Boston Life Sciences Roundup 08/03/12 Boston
Brightcove, Avalon, Bit9, & More from the Boston Deals Roundup 08/01/12 Boston
Mersana Brings in $27M and New Investors NEA and Pfizer 07/31/12 Boston
Mersana Therapeutics Secures $27,000,000 Series A Funding 07/31/12 Boston
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs 05/01/12 Boston
Liazon Receives $18,200,000 New Funding Round 04/24/12 New York
Page 1 of 3 next page »